Oricell Therapeutics

OriCell Therapeutics aims to develop drugs with good efficacy and affordable prices for tumor immunotherapy.

Operating in health care, pharmaceutical, product research based in Asia-Pacific (APAC), Oricell Therapeutics was founded in 2015.

Oricell Therapeutics is positioned in health care, pharmaceutical, product research, a segment that rewards a clear, focused offering.

The company is recorded as being based in Asia-Pacific (APAC).

Directory data places it at the Series_B stage.

Its team size is recorded as c_00101_00250 employees.

Total disclosed funding stands at about $210.5M.

Sector	Health Care, Pharmaceutical, Product Research
Headquarters	Asia-Pacific (APAC)
Country	CN
Founded	2015
Employees	c_00101_00250
Stage	series_b
Total funding	$210,492,876

Website: www.oricell.com/en

Emails and contact routes are reserved for registered members.
Create a free account

Browse related